Neurovascular device maker Rapid Medical said it won CE Mark approval in the European Union for its Tigertriever 13 stent retriever intended for treating ischemic stroke, and added that the first patient in the region has been treated with the device. The Israel-based company touted the Tigertriever 13 as the first-ever fully-visible stent retriever that can be […]
Vascular
Reva wins CE Mark for bioresorbable scaffold in below-the-knee PAD
Reva Medical (ASX:RVA) said yesterday it won CE Mark approval in the European Union for its Motiv bioresorbable drug-eluting scaffold, now cleared for treatment of below-the-knee peripheral artery disease. The San Diego-based company’s Motiv is made from the company’s proprietary radiopaque Tyrocore polymer designed for vascular scaffolds. Reva said that over the coming months, it will […]
Hancock Jaffe wins OK from ethics committee for FIH VenoValve trial
Hancock Jaffe Laboratories (NSDQ:HJLI) said today that Colombia’s Ethics Committee at Fundación Santa Fe de Bogotá approved a first-in-human trial of its VenoValve bioprosthetic valve. The Irvine, Calif.-based company’s VenoValve is a porcine valve designed to be implanted into the femoral or popliteal vein to treat lower limb chronic venous insufficiency from damage to leg vein valves […]
United Therapeutics $216m deal for SteadyMed clears HRS Act waiting period
United Therapeutics (NSDQ:UTHR) said today that it stepped closer to completing its $216 million acquisition of SteadyMed (NSDQ:STDY) after terminating the the HSR Act waiting period. The merger combines two companies that were in court as recently as last November, fighting over patents covering treprostinil, the active ingredient in both companies’ lead products. Read the whole story on our sister […]
Cook Medical touts launch, first use of Advance CS, Compass CT systems
Cook Medical today announced the launch and first use of its Advance CS coronary sinus infusion catheter and Compass CT disposable pressure transducer designed for treating heart failure patients. The CS catheter is a percutaneous balloon infusion catheter designed for use in retrograde coronary sinus infusion procedures to infuse therapeutic agents into the heart via the […]
Sales for Abbott’s diabetes business jump 40% in Q2
Abbott (NYSE:ABT) shares were up today after the healthcare company posted second-quarter financial results that topped estimates on Wall Street. For the three months ended June 30, Abbott posted profits of $733 million, or 41¢ per share, on sales of $7.77 billion. The company saw its quarterly profits grow 159% on sales growth of 17% compared with Q2 […]
Reva lands new partner in Italy for bioresorbable scaffold
Reva Medical (ASX:RVA) said today that it inked a deal with Bio Vascular Group to distribute Reva’s Fantom bioresorbable scaffold in Italy. The partnership expands Reva’s commercial activities to Italy, adding to its ongoing efforts in Germany, Switzerland, Austria and Turkey. Get the full story at our sister site, Drug Delivery Business News.
BD’s Bard wins third IVC filter bellwether
Becton Dickinson & Co. (NYSE:BDX) subsidiary C.R. Bard this week won a third inferior vena cava filter bellwether case after the statute of limitations expired on the claims, according to court documents. In the case, Bard faced allegations from plaintiff Carol Kruse claiming that it sold defective IVC blood filters intended to prevent pulmonary emboli. US District Judge […]
Cagent Vascular closes $12m Series B
Cagent Vascular said today it closed a $11.9 million Series B round of financing to help support expand manufacturing and a limited launch of the company’s Serranator Alto angioplasty device. The round was led by two strategic investors and joined by Balestier Investments, Ben Franklin Technology Partners, Synergy Ventures and other private investors, the Wayne, Penn.-based […]
Venous reflux cath dev Venclose closes oversubscribed Series B
Venous reflux disease treatment developer Venclose said this week it closed an oversubscribed Series B round of financing, but did not disclose the amount raised. The San Jose, Calif.-based company said that the round was joined by new and existing investors, and that proceeds from the round will help support new product development, manufacturing expansion […]
EchoNous wins FDA nod for EchoNous Vein ultrasound catheter guide
EchoNous said today it won FDA 510(k) clearance for its EchoNous Vein ultrasound device intended to improve peripheral IV catheter placements. The Seattle-based company said its EchoNous Vein system is designed to provide real-time, clear images at depths from one to five centimeters for visualizing superficial and deeper veins. “EchoNous Vein’s simple on-screen controls allows clinicians […]